AI-powered senior-focused digital health company CarePredict announced it scored $29 million in Series A-3 investment co-led by Aspire Healthtech Partners and SV Health Investors’ Medtech Convergence Fund.
Existing investors Las Olas Venture Capital and Secocha Ventures participated in the round, as did individual investors.
WHAT THEY DO
CarePredict offers an AI-enabled platform for senior care, combining wearable technology, indoor location tracking, deep machine learning and predictive analytics.
Its Tempo wearable includes sensors that can detect an individual’s activities of daily living, including bathing, drinking, eating, toileting, walking, sleeping and more. It also includes a touch-button call system to communicate with caregivers and provides an individual’s exact indoor location. The Tempo can also act as a key to unlock doors by touching the wearable to a paired door lock.
The funds will be used to accelerate the company’s growth.
“CarePredict has demonstrated excellent traction in senior housing and is well positioned to expand into the aging in place segment with a proven record of prediction and early intervention to not only preserve the health of older adults but to meaningfully affect healthcare costs positively,” Greg Madden, managing partner at SV Health Investors, said in a statement.
In 2019, the Florida-based company garnered $9.5 million in Series A funding.
At the height of the pandemic in 2020, the company rolled out a new set of contact-tracing tools designed for senior living facilities dubbed PinPoint.
The tools were broken up into four types of tracing: contact tracing, location tracing, path tracing and room traffic. The company said it used indoor location tech to identify where a staff member or patient was in the facility and who they came into contact with.
Other companies focused on senior care include digital health platform DUOS, which scored $10 million in funding last month, bringing its total raise to over $33 million. Boston-based Author Health, a hybrid care platform for Medicare Advantage members with serious mental illness and substance use disorders, launched last month with $115 million in financing.